ReviewFrontiers in oncology2018

Hematologic Tumor Cell Resistance to the BCL-2 Inhibitor Venetoclax: A Product of Its Microenvironment?

Joel D Leverson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.